NAYA – naya biosciences, inc. (US:NASDAQ)
Stock Stats
News
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
Form 10-Q NAYA Biosciences, Inc. For: Sep 30
Form 10-Q/A NAYA Biosciences, Inc. For: Jun 30
Form 10-K/A NAYA Biosciences, Inc. For: Dec 31
Form NT 10-Q NAYA Biosciences, Inc. For: Sep 30
Form SC 13G/A NAYA Biosciences, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.